Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
AstraZeneca
AZN
$263B
| $18.3M | 0.02% |
183,548
+176,244
| +2,413% | +$16.6M |
|
902
PUT
Lennox International
LII
$13.4B
| $18.3M | 0.02% |
75,000
+28,700
| +62% | +$7.12M |
|
903
TransUnion
TRU
$16.3B
| $18.3M | 0.02% |
213,672
-207,005
| -49% | -$17.2M |
|
904
CALL
Oracle
ORCL
$417B
| $18.3M | 0.02% |
344,700
-41,400
| -11% | -$2.28M |
|
905
CALL
Applied Materials
AMAT
$381B
| $18.3M | 0.02% |
299,100
-9,600
| -3% | -$540K |
|
906
Wintrust Financial
WTFC
$10.2B
| $18.3M | 0.02% |
257,459
-464,553
| -64% | -$31M |
|
907
iShares MSCI Canada ETF
EWC
$6.95B
| $18.2M | 0.02% |
610,447
+583,540
| +2,169% | +$17M |
|
908
Rigel Pharmaceuticals
RIGL
$873M
| $18.2M | 0.02% |
852,542
+87,730
| +11% | +$1.81M |
|
909
Navient
NAVI
$890M
| $18.2M | 0.02% |
1,332,990
+671,884
| +102% | +$9.04M |
|
910
Forward Air
FWRD
$588M
| $18.2M | 0.02% |
260,297
+207,854
| +396% | +$14.1M |
|
911
Bristol-Myers Squibb
BMY
$139B
| $18.1M | 0.02% |
282,257
-139,343
| -33% | -$7.98M |
|
|
LM
912
DELISTED
Legg Mason, Inc.
LM
| $18.1M | 0.02% |
504,002
-296,021
| -37% | -$11M |
|
|
AVYA
913
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $18.1M | 0.02% |
1,340,165
+1,045,012
| +354% | +$12.8M |
|
914
Abbott
ABT
$201B
| $18M | 0.02% |
207,652
-67,462
| -25% | -$5.65M |
|
|
GBT
915
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $18M | 0.02% |
226,700
+193,878
| +591% | +$11.5M |
|
|
ACC
916
DELISTED
American Campus Communities, Inc.
ACC
| $18M | 0.02% |
383,004
-768,833
| -67% | -$36.8M |
|
917
Paychex
PAYX
$44.5B
| $18M | 0.02% |
211,443
-521,779
| -71% | -$44M |
|
|
SPLK
918
DELISTED
Splunk Inc
SPLK
| $18M | 0.02% |
120,040
+83,093
| +225% | +$10.9M |
|
919
Xylem
XYL
$26.3B
| $17.9M | 0.02% |
+227,794
| New | +$17.7M |
|
920
Darden Restaurants
DRI
$25B
| $17.9M | 0.02% |
164,065
-91,638
| -36% | -$10.4M |
|
921
Comfort Systems
FIX
$55B
| $17.9M | 0.02% |
358,546
+2,999
| +0.8% | +$146K |
|
|
APLS
922
DELISTED
Apellis Pharmaceuticals
APLS
| $17.8M | 0.02% |
582,606
-2,128,655
| -79% | -$58.9M |
|
923
FirstCash
FCFS
$9.95B
| $17.8M | 0.02% |
221,065
-45,827
| -17% | -$3.85M |
|
924
Flowers Foods
FLO
$1.51B
| $17.7M | 0.02% |
814,810
-40,726
| -5% | -$885K |
|
|
FOLD
925
DELISTED
Amicus Therapeutics
FOLD
| $17.7M | 0.02% |
1,814,561
+485,220
| +37% | +$4.44M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.